MedPath
HSA Approval

CIPROFLOXACIN TABLET 500 mg

SIN09604P

CIPROFLOXACIN TABLET 500 mg

CIPROFLOXACIN TABLET 500 mg

January 10, 1998

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01MA02

ciprofloxacin

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

PT INDOFARMA

Active Ingredients

CIPROFLOXACIN HCl MONOHYDRATE EQV CIPROFLOXACIN

500 mg

Ciprofloxacin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CIPROFLOXACIN TABLET 500 mg - HSA Approval | MedPath